PRKACA and lymphoma: An increasing number of studies have shown that PRKACA may promote the progression of cancer through kinases, such as PKA catalytic subunits, which are detected in the extracellular serum in various cancers, such as lymphoma as well as colon, kidney, rectal, prostate, lung, and adrenal cancers [44].